Companies/US/CLDX

CELLDEX THERAPEUTICS, INC.

Income flow

Annual
CLDX 10-K Income StatementPeriod 2025-12-31Source 10-K
GrantUNIT_STA 1MServices & otherUNIT_STA 97,000RevenueUNIT_STA 2M-78% Y/YGross profitUNIT_STA 1MCost of revenueUNIT_STA 200,000

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2025-12-31 · 10-K · UNIT_STA
By activity
By activityUNIT_STA 1M
  • GrantUNIT_STA 1M100.0%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).0.00%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).0PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.0.0%Shares outTotal shares currently outstanding (issued and not retired).78.5MFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).73.0M
Dividend calendar
Pay date
2019-02-11
Stock splits
  1. 1:152019-02-11